U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H15BrO
Molecular Weight 231.13
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-BROMOCAMPHOR, (+)-

SMILES

CC1(C)[C@@H]2CC[C@@]1(C)C(=O)[C@H]2Br

InChI

InChIKey=NJQADTYRAYFBJN-FWWHASMVSA-N
InChI=1S/C10H15BrO/c1-9(2)6-4-5-10(9,3)8(12)7(6)11/h6-7H,4-5H2,1-3H3/t6-,7+,10+/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H15BrO
Molecular Weight 231.13
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/international/bromocamphor.html | https://www.ncbi.nlm.nih.gov/pubmed/21365113 | https://www.ncbi.nlm.nih.gov/pubmed/22357322 | https://www.rlsnet.ru/mnn_index_id_261.htm

3-Bromcamphor is camphor derivative, that used in Russia as a calming agent and an indirect anticoagulant in the form of tablets based on both left-hand-rotating and racemic isoforms of this compound. The use of racemic bromcamphor instead of the optically active forms is explained by the much (almost tenfold) lower cost at a comparable physiological activity of the former drug. Racemic bromcamphor has a lower melting point as compared to that of the left-hand-rotating isomer (48 – 53°C versus 71 – 76°C, respectively) and is susceptible to fusion at room temperature

Originator

Sources: Journal of the Chemical Society, Transactions, Volume 33, Pages 80-88, Journal, 1878

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Dobrocam

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Reactivity of endo-3-bromocamphor with sulfur-centered nucleophiles by an electron transfer mechanism. Electrophilic behaviour of the 3-camphoryl radical.
2011-04-21
Screening for new compounds with antiherpes activity.
1984-10
Patents

Patents

Sample Use Guides

Adults: for 0.15-0.5 g. BidChildren: under the age of 2 years - 0.05 g, 3-6 years - 0.1 g, 7-9 years - 0.15 g, 10-15 years - 0.15-0.25 g. Bid
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:35:37 GMT 2025
Edited
by admin
on Mon Mar 31 18:35:37 GMT 2025
Record UNII
E6SHQ2AT1P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3-BROMOCAMPHOR, (+)-
Systematic Name English
(1R-ENDO)-(+)-3-BROMOCAMPHOR
Preferred Name English
CAMPHOR, 3-BROMO-, D-
Common Name English
(1R,3S,4S)-(+)-3-BROMO-2-BORNANONE
Systematic Name English
2-BORNANONE, 3-BROMO-, (1R,3S,4S)-(+)-
Systematic Name English
CAMPHORA MONOBROMATA, (+)-
Common Name English
(+)-3-BROMOCAMPHOR
Systematic Name English
CAMPHOR,MONOBROMATED [VANDF]
Common Name English
CAMPHORA MONOBROMATA [HPUS]
Common Name English
BICYCLO(2.2.1)HEPTAN-2-ONE, 3-BROMO-1,7,7-TRIMETHYL-, (1R,3S,4S)-
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
233-652-1
Created by admin on Mon Mar 31 18:35:37 GMT 2025 , Edited by admin on Mon Mar 31 18:35:37 GMT 2025
PRIMARY
CAS
10293-06-8
Created by admin on Mon Mar 31 18:35:37 GMT 2025 , Edited by admin on Mon Mar 31 18:35:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID2022252
Created by admin on Mon Mar 31 18:35:37 GMT 2025 , Edited by admin on Mon Mar 31 18:35:37 GMT 2025
PRIMARY
FDA UNII
E6SHQ2AT1P
Created by admin on Mon Mar 31 18:35:37 GMT 2025 , Edited by admin on Mon Mar 31 18:35:37 GMT 2025
PRIMARY
PUBCHEM
512864
Created by admin on Mon Mar 31 18:35:37 GMT 2025 , Edited by admin on Mon Mar 31 18:35:37 GMT 2025
PRIMARY